AzTrials
AzTrials

Addiction DisordersPAPRICANCT06580756

Problematic Use and Addiction in Primary Care

An observational study of Addiction Disorders and Primary Care, run by University Hospital, Tours at 3 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The morbi-mortality and social cost of addictive disorders led the French authorities to set up a government plan in 2018 to combat drugs and addictive behavior (Interministerial mission to combat drugs and addictive behaviour - (MILDECA)). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Addiction Disorders, Primary Care
What is being tested?
Short training program
How many people
200 participants
Where
3 sitesFrance
Study dates
Sep 2025to Aug 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Primary care ambulatory professional

Who may be able to join

  • be a primary care professional (physiotherapists, nurses, midwives, dentists, pharmacists, General practitioner)
  • in ambulatory practice. Recruitment will be carried out with the help of territorial professional health communities, to include practitioners practicing in conditions representative of the diversity of primary care practice.
  • GPs agreeing to take part will be divided into a control group and an intervention group, by drawing lots.

Who cannot join

  • Refusal to participate.
  • The same participant may not be included in more than one stage.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France3 sites
  • CPTS Lanmeur

    Lanmeur, 29620

    Jean Yves LE RESTE, lereste@univ-brest.fr

  • CPTS Sud Lochois

    Ligueil, 37240

    Maxime PAUTRAT, maxime.pautrat@univ-tours.fr

  • CPTS du Vendomois

    Vendôme, 41100

    Alain AUMARECHAL, alain.aumarechal@univ-tours.fr

Other trials in France

About this study

Official title: Development and Validation of a Short Training Course to Help Primary Care Healthcare Professionals Identify Addictive Disorders

The morbi-mortality and social cost of addictive disorders led the French authorities to set up a government plan in 2018 to combat drugs and addictive behavior (Interministerial mission to combat drugs and addictive behaviour - (MILDECA)). In particular, it encourages early detection, which is the first stage in a validated global approach to the management of addictive disorders. Improving early identification of addictive disorders in primary care would reduce morbidity and mortality and improve quality of life for patients with addictive disorders. The identification of use disorders should be systematic in primary care and was the subject of a recommendation in 2015. Numerous tests are cited in these recommendations, but few have actually been validated in primary care, and none has been shown to be feasible. For example, only 23% of GPs claim to systematically identify alcohol consumption.

Other primary care professionals (physiotherapists, nurses, midwives, dentists, pharmacists) also have a role to play in identifying addictive disorders. The evolution of their respective professions (delegation of tasks, creation of the profession of advanced practice nurse, medical assistants) and the recent reorganization of the practice framework, both in terms of practice structures and professional community organizations, involve them in a global multidisciplinary collaboration on patient care, particularly in the early identification of addictive disorders.

Read more

The hypothesis is that the difficulties in implementing tests to identify addictive disorders in primary care are linked to the lack of specific consideration of the needs of primary care patients and caregivers.

The overall aim of the study is to improve the early detection of addictive disorders through brief training for primary care healthcare professionals.

Read the detailed description

The project comprises three successive stages:

  1. Design a training program with content tailored to primary care professionals;
  2. Evaluate the feasibility and acceptability of the training;
  3. Evaluate the implementation of this training program by comparing the incidence of addiction disorder detection by primary care professionals between a trained and an untrained group.
Being tested
Short training program
Keywords
short training program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Short training programOther

    Training in the early identification of addictive disorders in primary care

Study groups in NCT06580756
Study groupRoleWhat they receive
group interventionGroup with a brief training
Receives: Other: Short training program
group controlGroup without a brief training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients who received information about the addictive disorders from the primary care professional

    The main aim of the study was to measure the effect of brief training in the identification of addictive disorders on the rate of patients who actually received the information from the primary care professional.

    Measured: 24 months

  2. number of patients identified with an addictive disorder from the primary care professional

    The main aim of the study was to measure the effect of brief training in the identification of addictive disorders on the rate of patients who actually received the information from the primary care professional.

    Measured: 24 months

Secondary outcomes (2)
  1. prevalence of addictive disorders in primary care

    Measure the prevalence

    Measured: 24 months

  2. types of addictive disorders

    List of addictive disorders identified in patients

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2024
  2. Study startSep 2025 (estimated)
  3. Primary completionAug 2028 (estimated)
  4. Study completionAug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06580756
Sponsor's protocol ID
DR230127-PAPRICA
Acronym
PAPRICA
Status last verified
Dec 2024
First submitted
22 Aug 2024
Last updated
9 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Addiction Disorders and Primary Care, run by University Hospital, Tours at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maxime PAUTRAT (02 47 59 61 52 ext. +33, maxime.pautrat@univ-tours.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients who received information about the addictive disorders from the primary care professional (time frame: 24 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in